Abnormalities cause most cancers in the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin pathway, hypoxia-inducible factor (HIF), and vascular endothelial growth factor (VEGF) expression. This evidence concerns the gene VEGFA and cancer.